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This two-phase study examines a physician’s use of one of five different types of technology to 
note a patient’s symptoms during the medical interview.  In this between-subjects design, 342 
undergraduates viewed one of several videos that demonstrated one condition of the 
doctor/patient interaction. After viewing the interaction, each participant completed a series of 
questionnaires that evaluated their general satisfaction with the quality of care demonstrated in 
the medical interview. A main effect of technology condition was present in both phases. 
Further, in Phase 2 we found that drawing the participant’s attention to the type of technology 
used has a divergent effect on their general satisfaction with the doctor/patient interaction 
depending on the technology condition. These findings have implications for healthcare 














The Use of Different Technologies During a Medical Interview: 
 
Effects on Perceived Quality of Care 
 
Few people go an entire year without a visit to some variety of the doctor’s office. 
Healthcare is a top priority in political platforms, a major driving force for research, and a 
substantial portion of yearly expenditures. In fact, in the US, an upwards of 400 billion dollars 
are spent each year on health-care related paperwork alone (Gladwell, 2005). Because of 
healthcare’s ubiquitous importance, the recent focus on the quality of care in the medical office 
follows logically.  
Nuances of the Doctor-Patient Interaction 
Arguably, the interaction between doctor and patient during the medical consultation is 
the most critical point for transferring information and the delivery of excellent healthcare 
(Bertakis, 1991; Ong, de Haes, Hoos, & Lammes, 1995; Russuvuori, 2001). During a successful 
medical interview, several steps must take place. The physician must become familiar with the 
patient’s history through direct communication, consultation with medical records if available, or 
a combination of the two. In order to obtain useful information from the patient, the physician 
must first determine the patient’s problems. The patient must be able to convey their symptoms 
in a way that is meaningful to the physician. Once the patient has explained the symptoms, the 
physician must mentally translate from laymen’s terms to medical vernacular, use prior 
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knowledge or reference materials to diagnose, and suggest treatment. Each step of this 
interaction is complicated by the context of individuals of non-equal positions of power and 
status (Ong et al., 1995; Steilhaug & Malterud, 2003). 
Quality of Care 
 There are at least two aspects to healthcare quality: actual patient outcome (observable 
consequences due to a medical encounter); and perceived quality of care (the patient’s personal 
perception of the quality of care). Actual patient outcome can be measured in several ways 
including: adherence to doctor recommendations, recall of information given during 
consultation, and understanding of diagnosis (Ong et al., 1995). Perceived quality of care (QoC) 
is a good predictor of actual patient outcome (Ong et al.). The most widely accepted assessment 
of perceived QoC, and the measure that is considered in this study, is patient satisfaction. Ong et 
al. report that patients evaluate their overall healthcare experience on their doctor’s interpersonal 
skills; skills which are largely interpreted through the use of non-verbal communication. 
Verbal Versus Non-verbal Communication 
At the time when the importance of the medical interview first came under researchers’ 
scrutiny, only the verbal components of communication were studied. Since then, the focus has 
shifted to non-verbal components of communication. Non-verbal communication has been 
operationalized as body positioning, posture, gaze, voice tone, etc. These non-verbal 
components, or visual cues, make up 77% of perceived interpersonal communication (Ong et al., 
1995). Although the verbal communication that takes place in each step of a medical interview is 
also important, this study focuses on non-verbal communication.   
 Shifting focus. While conducting the medical interview, a physician must often times 
consult two major sources of information simultaneously: a) the patient’s medical records and b) 
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the patients themselves. Previous research has shown that patients often believe that their 
physician is not listening to them when attention is shifted from the patient to the records 
(Ruusuvuori, 2001). This attentional shift often entails a physical shift of the physician’s head or 
head and upper torso depending on the way the physician is oriented relative to the patient and 
the patient’s records (Ruusuvuori). Even the most minimal physical shift still requires that the 
doctor’s gaze move from the patient to the records, thus making eye contact between the doctor 
and patient impossible to maintain. 
Eye contact. During any face-to-face conversation, eye contact lets the speaker know that 
the recipient is focused on them. For a patient who may be anxious the need to know the 
physician is engaged in the conversation is heightened. Commonly, tactics are employed by 
speakers to regain eye contact with an intended recipient whose gaze has wandered. One such 
tactic is achieved by pausing mid-sentence, or engaging in other speech discontinuities until the 
recipient’s gaze is regained (Goodwin, 1981). This same occurrence has been observed during 
medical interviews, indicating that the patient is perturbed by the loss of their physician’s gaze 
(Ruusuvuori, 2001). 
Body orientation. A final form of non-verbal communication examined in this study is 
body positioning. Even when eye contact is maintained, the speaker’s torso may or may not be 
facing the recipient. When the speaker’s torso is squared off with the recipient, the speaker’s 
head may remain in its resting state. This scenario is termed a 0º body orientation in the current 
study. The other case examined in this study is one where the speaker’s torso is facing 90º with 
respect to the recipient. The 90º body orientation requires the speaker to torque in order to face 
the recipient (see Figure 1). Evidence has shown that people prefer the 0º body orientation to the 
90º when speaking to someone (Ruusuvuori, 2001; Furnham, Petrides, & Temple, 2006; Ong et 
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al., 1995). 
Note Taking 
 Earlier, the potentially problematic situation of simultaneous consultation of both the 
patient and the patient’s medical records was discussed. There is a third component, namely, the 
notes a physician may take during the medical interview. Taking notes allows a health provider 
to a) record the patient’s symptoms and concerns in order to update medical records and b) refer 
back to different points of the interview to seek further clarification if needed. Ruusuvuori 
(2001) would argue that note taking affords a crucial written record because doctors otherwise 
tend to overlook problems presented subsequent to the beginning of the medical interview. Notes 
may be taken during the interview with the use of pen and paper, an electronic device, or not at 
all until the doctor leaves the examination room. Although healthcare providers differ in their 
mode of note talking, little research has examined the effect of these differences on patient 
satisfaction. 
Technology’s Influence on Non-verbal Cues 
 Caldwell, Mauney, Lyon, et al. conducted Phase 1 of this investigation of technology use 
on patient satisfaction (2006). The authors employed a novel methodology in which participants 
viewed a prerecorded doctor-patient interaction and then completed questionnaires that assessed 
their evaluation of the QoC. Phase 1 used a between-subjects design that exposed participants to 
the doctor’s use of one of several different technologies. One major finding from that study was 
that participants were unsatisfied with the doctor’s use of a desktop computer. This condition 
was rated significantly lower than others with regard to every subscale of perceived QoC, which 
supported the authors’ hypothesis that perceived quality of care will increase when technology is 
less obtrusive. 
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Other Influences 
 In addition to examining different technologies, Caldwell et al. also examined the 
influence of body orientation and gender. The overwhelming suggestion in the literature is that 
body position and gender matching of the doctor and patient do have an effect on reported 
satisfaction (Steilhaug & Malterud, 2003; Ruusuvuori, 2001; Furnham, Petrides, & Temple, 
2006; Ong et al., 1995). Although Caldwell et al. did not find a significant main effect for body 
position or gender; they did find a general trend that the 0 degree condition led to higher reported 
likelihood of a return visit in some technology conditions. The authors concluded that body 
orientation might be an influence in some conditions, but not others.  
Phase 2 
 Phase 2 is a replication and extension of the work of Caldwell et al. (2006). In Phase 1, 
the type of technology used in each condition was not explicitly pointed out or explained to the 
participants until the debriefing period. As a result, it remained unclear whether participants 
could distinguish the type of technology the doctor was using in each condition. Specifically, the 
most novel form of technology, a wearable computer, may have been confused for a more 
common device, such as a personal digital assistant (PDA). It may be that the explicit 
mentioning of the doctor’s use of technology will cause the patient to include the technology in 
their QoC evaluation. Furthermore, the mentioning of technology prior to viewing may draw the 
participant’s attention to the fact that the doctor is not taking notes in the ‘nothing’ condition. For 
this reason, the current study included a one to two sentence explanation of the doctor’s note-
taking technology stated prior to the video viewing (see Appendix 1).  
Similarities. Caldwell et al. found the desktop computer received significantly lower QoC 
subscale scores than every other technology condition (2006). All participants reported on the 
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Technology Use survey that they use a desktop computer on a daily basis. Since a desktop 
computer is a highly recognizable and familiar item to these participants, and was anticipated to 
be so for the future participants, the explicit explanation of technology should have no effect on 
preference for the desktop computer. Likewise, the explicit explanation of the use of the pen and 
paper and PDA is not expected to enhance participant’s understanding of these conditions, 
therefore it is likely that QoC scores will not be significantly different from those obtained in 
Phase 1  
 Differences. Caldwell et al. suggest an explanation for the relatively high rating of the 
wearable computer condition; namely, that the wearable computer is so inconspicuous that 
participants did not recognize it as a novel technology. Indeed, as can be seen in Figure 2e, the 
visual display attached to the “doctor’s” eyeglasses is barely discernible and the Twiddler might 
be mistaken for a PDA or other familiar, handheld device. It is expected that overall satisfaction 
for the wearable computer condition will be significantly higher than they were in Phase 1. Also, 
the expected results would show a significantly lower satisfaction scores for the wearable 
computer (because of its novelty) than the nothing, pen and paper, and PDA conditions. 
 The explicit explanation of each technology condition prior to the video viewing is 
expected to make one further difference. In the condition where the doctor relies on his memory 
rather than taking notes, participants will be told, “The doctor may or may not use pen and paper 
to input the patient’s symptoms and concerns in order to update the patient’s records.” This 
statement may draw the participant’s attention in the “nothing” condition to the fact that the 
doctor is not taking notes and they may conclude that he is not providing high quality health 
care. If this is the case, then it is expected that the satisfaction ratings will decrease compared to 
Phase 1 results. 
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Phase 2 Hypotheses 
Hypothesis 1: There will be a significant main effect of technology condition, thus replicating 
the previous study.  
Hypothesis 2: There will be a significant phase by technology interaction caused by the explicit 
technology statement.  
Hypothesis 2a:   The most novel device, the wearable computer, will receive higher 
ratings when compared to the previous ratings obtained by Caldwell and colleagues. 
Hypothesis 2b: Patient satisfaction for the paper and pen, PDA, and desktop computer 
conditions will not be significantly different in the current study than they were in the 
previous study. 
Hypothesis 2c: The condition where no notes are taken will receive lower ratings when 
compared to results obtained by Caldwell and colleagues. 
Hypothesis 3: It is expected that there will be no main effect of body orientation. Although the 
literature suggests that the 0º condition would be rated more favorably than the 90º, Caldwell et 
al. did not find this main effect. Since this study uses the same methodology, similar results are 
expected.  
Hypothesis 4: It is expected that there will not be a main effect of gender. Again, the literature 
suggests that this effect would be significant and again this is not what Caldwell et al. found.   
Method 
Phase 2 Participants 
Two hundred undergraduate students (103 male and 97 female) at a southeastern 
technical institute participated for extra credit in psychology courses. Participants ranged 
between 18 and 25 with a mean age of 19.6 years. Participants were recruited through 
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Experimetrix, an online experiment sign-up system.  
Apparatus and Stimuli 
Videos. In this between-subjects design, each participant watched one of ten brief videos 
of a medical interview between a doctor and patient. During the interview, the doctor is 
ascertaining the patient’s symptoms and concerns. “The doctor” in the video is played by a 27 
year-old, Caucasian male (see Figure 2). The camera angle of the video is as if the patient were 
sitting approximately three feet in front of the physician. The male patient can be heard, but not 
seen, while reporting his symptoms of an upper respiratory infection, or a common cold, such as: 
headache, fatigue, loss of appetite, coughing, and so on. Participants could see, as well as hear, 
the actor posing as a doctor. The film is set in a mock-up of a doctor’s office including a desk, 
lamp, medical poster, jar of cotton balls, and plant. The scenario in the film reflects an ordinary, 
non-emotional visit to the doctor’s office that any undergraduate would experience for a 
common illness. In order to control the dialogue across all videos, the patient’s responses were 
audio recorded in advance and this identical version was overlaid to be the audio track for all 
videos. 
 Viewing. The DVD quality videos were projected onto a standard projection screen at a 
viewing distance of approximately 10 feet. The participants were seated at a table, facing the 
screen and will range in number from 1 to 8 during any given session; however, participants’ 
responses were completely individual. The projection screen was approximately 5’ by 6.5’ (see 
Figure 3).  
Questionnaires. This study used four questionnaires to assess each participant’s 
satisfaction with the QoC demonstrated in the video. These included a Background 
Questionnaire, a Quality of Care survey, an After Video Response sheet, and a Technology Use 
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survey. The Background Questionnaire was used to collect demographic information as well as 
answers to questions such as, “Are you in good health?” The Quality of Care survey consists of 
25 questions that address five subscales of QoC such as, “communication”. The After Video 
Response sheet gave participants a chance to respond freely whether they would choose to go to 
this doctor, comment about the video, or comment about the study in general. The Technology 
Use survey established the participant’s familiarity and regular use of a variety of technologies 
such as a cellular phone or cruise control.   
Variables 
Independent variables. The independent variables in this study are the type of technology 
used by the physician to input the patient’s responses, the orientation of the physician relative to 
the patient, and the gender of the participant. Five technology conditions were used (nothing, pen 
& paper, PDA, desktop computer, and wearable computer) along with two physician-patient 
orientations (0 degrees and 90 degrees) for a total of ten conditions, each represented in videos of 
length 2 minutes and 34 seconds ± 7 seconds (see Figure 2). The 0 degree condition is the case 
when the doctor is sitting face-to-face with the patient. The 90 degree condition is the case when 
the doctor is facing 90 degrees away from the patient so that he must torque his body to make 
direct eye contact (see Figure 1).  
Dependent variables. The dependent variable in this study is the general satisfaction and 
will be operationally defined by participant responses to the four questionnaires previously 
described. Specifically, the response to the question, “Would you go to this doctor” was used as 
a measure of participant’s QoC perception. 
Technologies 
The use of the word “technologies” in this study is used to mean the device or method used 
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by the healthcare provider to take notes throughout the entire medical interview. These devices 
and methods are either currently used or could easily be implemented in a doctor’s office. (See 
Figure 2). 
• Nothing: This condition represents the case where the physician does not take any sort of 
notes, but rather relies on his own memory. 
• Paper and pen: The doctor takes hand-written notes onto a pad or directly onto the 
patient’s chart. 
• Personal Digital Assistant (PDA): The doctor is able to electronically store the patient’s 
responses with a PDA and stylus. Additionally, the doctor is able to reference material 
such as patient history or drug interactions. 
• Desktop Computer: This condition provides all the same functions as the PDA, but is 
visibly more noticeable. Also, instead of the use of a stylus, the doctor uses a keyboard 
and mouse as input devices. 
• Wearable Computer: The participants will likely have least (if any) familiarity with this 
device, as it is the newest of the technologies. The wearable computer consists of a small 
display attached to the physician’s glasses (which may or may not be noticed) and a 
handheld keyboard known as a Twiddler.  
Procedure 
After completing an informed consent form and filling out the Background 
Questionnaire, participants were instructed that they would be viewing a brief video of a doctor 
and a patient interaction. The participants were also informed that the interaction was only part 
of the visit and to assume that a check-up will follow after the initial interview. The type of 
technology used in the participant’s particular condition was then brought to their attention. This 
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step differs from the original study, which took pains to ensure the use of technology was not 
mentioned at all until the debriefing stage. Lastly, the participants were informed that they would 
be given some questionnaires to complete after watching the video that would evaluate their 
perception of the doctor-patient interaction. Once the video was complete, the participants were 
given the Quality of Care Questionnaire, then the After Video Response sheet, and then the 
Technology Use survey, in that order. Finally, the participants were debriefed.  
Analysis and Results 
Phase comparison  
As in the Phase 1, the between-subjects factors: gender, technology condition, and 
doctor’s body orientation were analyzed. For all analyses, the Phase 1 data and Phase 2 data were 
included. Both phases were analyzed separately so that the new and old data could be directly 
compared. An alpha level of .05 was used throughout. 
Hypothesis 1: Main Effect of Technology Condition 
 To test Hypothesis 1, a one-way ANOVA was run with technology condition as the 
independent variable and the percentage of participants reporting that they would go to the 
doctor, as obtained from the after video questionnaire, as the dependent variable (see Figure 4).  
Phase 1 showed a significant main effect of technology condition, F(4,137) = 3.063, p = .019, as 
did Phase 2, F(4,194) = 3.303, p =.012. Table 1 shows the ANOVA summary table for each 
phase. This provides support for Hypothesis 1. 
Hypothesis 2: Technology Condition by Phase Interaction 
 To test Hypothesis 2, an ANOVA was run with phase and technology condition as fixed 
factors and the percentage of participants reporting that they would go see the doctor as the 
independent variable. Again, this analysis supported Hypothesis 1, showing a main effect of 
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technology condition, F(4, 341) = 4.264, p = .002. The main effect of phase was not significant, 
F(1,341) = 0.210, p = .647, but the interaction between phase and technology condition was 
marginally significant, F(1,341) = 2.207, p=.068, (see Table 2). 
Hypotheses 2a, 2b, and 2c 
To test hypotheses 2a, 2b, and 2c, five independent samples t-tests were run, one for each 
technology condition comparing the reported percentage of Phase 1 participants who would go 
see the doctor to those in Phase 2. In the ‘nothing’ condition, Phase 2 participants reported 
significantly lower willingness to see the doctor (37.8%) than Phase 1 participants (65.5%), 
t(64)=2.286, p = .026. This supports the predictions of Hypothesis 2a. The t-tests for every other 
technology condition show that the means were not significantly different between Phases 1 and 
2: pen & paper, t(66) = -0.419, p = .677; PDA, t(66) = 0.865, p = .390; desktop computer t(65) = 
-1.655, p = .103; and wearable computer t(70) = -0.099, p = .921. Therefore, Hypothesis 2b was 
supported while Hypothesis 2c was not (see Table 3).  
Hypothesis 3 & 4 
A one-way ANOVA using body orientation (0° and 90°) as the independent variable and 
the percentage of participants who would go to the doctor as the independent variable showed 
that, in Phase 2, there is not a main effect of body orientation, F(1,191) = .297, p = .586. This 
replicates the results found by Caldwell et al. in Phase 1, F(1,140) = .648, p = .422, (see Table 
4). Likewise, a one-way ANOVA with gender as the independent variable and the percentage of 
participants who reported that they would go to the doctor as the independent variable did not 
yield significant results for Phase 1, F(1,198) = .215, p = .643, or Phase 1, F(1,140) = .127, p = 
.722,  (see Table 5). 
Discussion 
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 Hypotheses 1, 2, 2a, 2b, 3, and 4 were supported. Hypothesis 2c was rejected. It may be 
that this technology savvy population was familiar enough with the wearable computer that the 
explicit statement did not further their understanding, much as was expected for pen and paper, 
PDA, and desktop computer. Hypothesis 3 and 4 were expected because of Phase 1 results, but is 
still not understood in the context of the literature. This study replicates a novel methodology 
that blends a naturalistic, yet highly controlled portrayal of a medical interview. The importance 
of this study and its predecessor is that they examine a gap in a field that is currently being 
researched heavily. The study will have to be replicated more to control for extraneous factors. 
The more the medical field shifts from its once autocratic style, the more studies such as the 
current one will be needed. 
A recent emphasis on patient-centered medical care has created a need for questions 
about patient preferences to be answered. The benefit of this design is that it is relatively 
economical and easily altered, making it feasible explore various aspects in the future. The least 
demanding extension of this study would be to show identical videos to an alternate population. 
To date, the participants have been undergraduates who are enrolled in a technical institution. A 
ceiling effect has been found on the Technology Use questionnaire for this population. Being 
both young and technologically savvy, there are not many devices that this population has no 
familiarity with. A sample of older adults, for instance, may reveal very different trends.  
 Gender match between patient and physician has previously been found to predict patient 
satisfaction, particularly for females (Furnham, Petrides, & Temple, 2006). However, the current 
and Caldwell et al.’s results did not support gender preferences. Although the intention was for 
the participant to imagine themselves in “the doctor’s” office, it is possible that both male and 
female participants perceived the doctor and patient to be gender-matched because the voice of 
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both doctor and patient were male. An easy manipulation to test this possibility would be to re-
record the patient responses with a female voice. If satisfaction scores decreased, one could infer 
that gender match or mismatch perceptions are based on the gender of the voices in the video.  
 The subject-matter of the current video was purposely chosen to be non-emotional. 
Previous literature states that severity of the illness being discussed drastically changes the 
dynamics of the medical interview (Ong et al., 1995). Once the effects of use of technology with 
non-emotional illnesses have been well established, the videos could be re-filmed with a more 
critical diagnosis such as breast cancer or Parkinson’s disease. Satisfaction with healthcare 
quality may be different across technologies depending on the severity of illness. Along the same 
lines of more severe illnesses, some diagnoses may affect participants of varying ethnic 
backgrounds differently. For instance, sickle-cell anemia might be an illness that African 
Americans are more familiar with and more wary of. Again, the videos could be re-filmed to 
examine the effect of racially sensitive illnesses. 
 Another important dynamic that could easily be studied using the design of the current 
study is that between pediatrician, child, and parent. Less is known about this triad than the more 
common doctor-patient interaction. However, the same sorts of issues of communication, 
interpersonal skills, and child/parent satisfaction have been examined. The major difference in 
this dynamic is that the younger the child is and the more the child’s parent tends to talk, the less 
the child tends to contribute to the conversation (Wassmer et al., 2004). Though children 
represent a smaller portion of the population than adults do, this line of research is just as 
important. 
 Assuming that the expected results are found, this study will have implications that 
should be considered by healthcare providers. Perhaps by explaining why and how devices will 
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be used throughout the medical interview and check-up, physicians can alleviate some of the 
negative perceptions participants tend to have about such devices. Although increasing perceived 
quality of care is important, the ideal goal is to integrate optimal satisfaction with the most 
effective, efficient methods possible. Although participants may not initially like a novel device, 
an increased understanding of the potential benefits may persuade popular opinion.     
Combined Phase Analysis 
 Initial analyses of Phase 1 and Phase 2 included a univariate analysis using the 
percentage of participants reporting that they would go to the doctor (YESGO) as the only 
dependent variable. Furthermore, identical independent variables (gender, body orientation, 
technology condition) were used in Phase 2 for ease of comparison with Phase 1. Once the 
phases were combined, YESGO was further analyzed in order to exhaust all possible 
independent variables. The participants’ major, age, recent health, number of doctor’s visits in 
the past year, level of familiarity with technological devices, and level of familiarity with 
computers were independently analyzed using YESGO as the dependent variable. Of the 
resulting univariate ANOVAs, only major was significant, F= 2.008, p=0.077, and age was 
marginally significant, F = 1.359, p = 0.059.  
 Multivariate analyses included YESGO and Quality of Care questions 1-25 as dependent 
variables. Quality of Care questions were further categorized into five subscales: Technical 
Quality (TECH), General Satisfaction (GSAT), Interpersonal Aspects (INTER), Communication 
(COMM), and Time Spent with the Doctor (TIME). Correlations were run on the questions 
within each subscale to ensure that the questions were measuring a common element. 
Multivariate analyses using the 26 dependent variables were run with Major, Age, TechCond, 
Gender, and Phase as independent variables. Next, the same independent variables were used in 
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multivariate analyses using the five subscales as dependent variables. Finally, interactions were 
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levels are not guaranteed.
b. 
Alpha =  .05.c. 
Case Processing Summary
324 90.3% 35 9.7% 359 100.0%
YESG O * Number of
doctor's visits in the
last year
N Percent N Percent N Percent
Valid Missing Total
Cases
YESGO * Number of doctor's visits in the last  year Crosstabulation
Count
19 85 32 10 146
1 1
26 106 30 15 177






0 visits 1-2 visits 3-4 visits
5 or more
visits
Number of doctor's visits in the last ye ar
Total





































4 cells (33.3%) have expected count less than 5. The













Number  of doctor's
visits in the last year
Value Label N
Tests of  Between-Subjects Effects
Dependent Variable: YESGO
.374a 3 .125 .501 .682
58.976 1 58.976 236.988 .000












of Squares df Mean Square F Sig.




.0228 .08266 .993 -.1907 .2363
.0937 .09737 .771 -.1578 .3451
-.0222 .12444 .998 -.3436 .2991
-.0228 .08266 .993 -.2363 .1907
.0708 .07248 .762 -.1163 .2580
-.0450 .10610 .974 -.3190 .2290
-.0937 .09737 .771 -.3451 .1578
-.0708 .07248 .762 -.2580 .1163
-.1159 .11792 .759 -.4204 .1887
.0222 .12444 .998 -.2991 .3436
.0450 .10610 .974 -.2290 .3190
.1159 .11792 .759 -.1887 .4204
(J) Number of doctor's
visits in the last year
1-2 visits
3-4 visits
5 or  more visits
0 visits
3-4 visits
5 or  more visits
0 visits
1-2 visits




(I) Number  of doctor's




5 or more visits
Mean
Difference






Based on observed means.































Number  of doctor 's








Means for groups in homogen eous subsets are
displayed.
Based on Type III Sum of Squares
The err or term is Me an Square(Error) =  .249.
Uses Harmonic Mean Sample Size = 48.001.a. 
The  group sizes are unequal. The harmonic
mean of th e group siz es is used. Type I error
levels are not guaranteed.
b. 
Alpha =  .05.c. 
Case Processing Summary
33 100 .0% 0 .0% 33 100 .0%
33 100 .0% 0 .0% 33 100 .0%
51 100 .0% 0 .0% 51 100 .0%
17 100 .0% 0 .0% 17 100 .0%
37 100 .0% 0 .0% 37 100 .0%
31 100 .0% 0 .0% 31 100 .0%
29 100 .0% 0 .0% 29 100 .0%
38 100 .0% 0 .0% 38 100 .0%
36 100 .0% 0 .0% 36 100 .0%
35 100 .0% 0 .0% 35 100 .0%





























N Percent N Percent N Percent
Valid Missing Total
Cases
Medical Technology     25 



































































Tests of Between-Subjects Effects
Dependent Variable: YESGO
3.992b 18 .222 .833 .654
13.450 1 13.450 50.540 .000




3.008c 16 .188 .984 .487
19.572 1 19.572 102 .458 .000




5.669d 17 .333 1.489 .138
11.900 1 11.900 53.133 .000




3.361e 17 .198 .740 .747
7.072 1 7.072 26.479 .000




3.180f 14 .227 .889 .575
9.022 1 9.022 35.302 .000










































of Squares df Mean Square F Sig.
R Squared = . 242 (Adjusted R Squared = -.048)b. 
R Squared = .236 (Adjusted R  Squared = -.004)c. 
R Squared = . 336 (Adjusted R Squared = .110)d. 
R Squared  = .204 (Adjusted R Squared = -.072)e. 
R Squared = . 179 (Adjusted R Squared = -.022)f. 






























































Tests of Between-Subjects Effects
Dependent Variable: Number of technoloical devices checked
.136b 1 .136 .008 .928
109556.379 1 109556.379 6525.553 .000




23.338c 1 23.338 1.562 .216
82925.338 1 82925.338 5551.446 .000




3.588d 1 3.588 .218 .642
110378.176 1 110378.176 6701.621 .000




22.889e 1 22.889 1.342 .251
116990.053 1 116990.053 6859.584 .000




10.917f 2 5.459 .404 .669
14924.414 1 14924.414 1105.480 .000










































of Squares df Mean Square F Sig.
R Squared = . 000 (Adjusted R Squared = -.015)b. 
R Squared = .023 (Adjusted R  Squared = .008)c. 
R Squared = . 003 (Adjusted R Squared = -.012)d. 
R Squared  = .020 (Adjusted R Squared = .005)e. 
R Squared = . 012 (Adjusted R Squared = -.017)f. 










































Length of  time one has used computers
1 .3 .3 .3
7 2.0 2.0 2.3












Highest frequecy of computer use
1 .3 .3 .3
1 .3 .3 .6
5 1.5 1.5 2.1
43 12.6 12.6 14.7
189 55.3 55.4 70.1
102 29.8 29.9 100 .0





several days per  week
daily, but infrequ ently
daily, frequently










Recent frequecy of computer use
9 2.6 2.6 2.6
46 13.5 13.5 16.1
87 25.4 25.4 41.5
200 58.5 58.5 100.0
342 100.0 100.0
1-5 hours per week
5-10 hours

































Case Process ing Summary
342 100.0% 0 .0% 342 100.0%
341 99.7% 1 .3% 342 100.0%
342 100.0% 0 .0% 342 100.0%
Length of time one has
used computers  *
YESG O
Highest frequecy of
computer use  * YESGO
Recent frequecy of
computer use  * YESGO







































341 99.7% 1 .3% 342 100.0%YESG O * HEALTHY
N Percent N Percent N Percent
Valid Missing Total
Cases



















































4 cells (66.7%) have expected count less than 5. The
minimum expected count is .02.
a. 
Descriptive Statistics
134 .00 1.00 .5336 .49886
134
17 .00 1.00 .5294 .51450
17
43 .00 1.00 .6047 .49471
43
47 .00 1.00 .3830 .49137
47
7 .00 1.00 .8571 .37796
7
21 .00 1.00 .7619 .43644
21
1 .00 .00 .0000 .
1
2 1.00 1.00 1.0000 .00000
2
5 .00 1.00 .8000 .44721
5
1 .00 .00 .0000 .
1
43 .00 1.00 .5814 .49917
43
4 .00 .00 .0000 .00000
4
9 .00 1.00 .4444 .52705
9













































N Minimum Maximum Mean
Std.
Deviation









































































Tests of  Between-Subjects Effects
Dependent Variable: YESGO
6.080a 13 .468 1.957 .024
14.954 1 14.954 62.583 .000












of Squares df Mean Square F Sig.
R Squared  = .072 (Adjusted R Squared = .035)a. 




















































































































.997 1210.693a 26.000 107.000 .000
.003 1210.693a 26.000 107.000 .000
294 .187 1210.693a 26.000 107.000 .000
294 .187 1210.693a 26.000 107.000 .000
.914 1.254 104.000 440.000 .063
.348 1.252 104.000 427.037 .064
1.233 1.251 104.000 422.000 .066
.502 2.123b 26.000 110.000 .004
.173 .859a 26.000 107.000 .662




.209 .859a 26.000 107.000 .662
2.171 .918 338.000 1547.000 .837
.083 .907 338.000 1289.738 .864
2.885 .898 338.000 1367.000 .890
.599 2.744b 26.000 119.000 .000
1.331 .875 208.000 912.000 .882
.223 .869 208.000 836.801 .893




.569 .702 104.000 440.000 .985
.537 .697 104.000 427.037 .987




4.323 .940 728.000 3432.000 .853
.006 .931 728.000 2165.798 .877
6.406 .925 728.000 2732.000 .904
.998 4.703b 28.000 132.000 .000
1.165 .868 182.000 791.000 .880
.270 .862 182.000 737.444 .889
1.480 .856 182.000 737.000 .900
.416 1.807b 26.000 113.000 .018
1.276 .731 234.000 1035.000 .998
.244 .717 234.000 933.533 .999
1.569 .706 234.000 947.000 .999
.343 1.516b 26.000 115.000 .071
2.849 .848 494.000 2375.000 .989
.037 .836 494.000 1722.310 .992
3.906 .831 494.000 1997.000 .994
.833 4.003b 26.000 125.000 .000
.898 .935 130.000 555.000 .677
.362 .936 130.000 532.174 .671
1.157 .938 130.000 527.000 .665
.457 1.952b 26.000 111.000 .009
1.871 .838 312.000 1416.000 .974
.119 .830 312.000 1205.618 .978
2.446 .824 312.000 1262.000 .982
.521 2.364b 26.000 118.000 .001
3.854 .851 702.000 3432.000 .996
.010 .841 702.000 2126.540 .997
5.633 .843 702.000 2732.000 .997
1.048 5.125b 27.000 132.000 .000
3.973 .882 702.000 3432.000 .982
.009 .876 702.000 2126.540 .982
5.877 .880 702.000 2732.000 .982
1.059 5.178b 27.000 132.000 .000
1.387 .919 208.000 912.000 .772
.200 .938 208.000 836.801 .713
1.893 .958 208.000 842.000 .644
.664 2.911b 26.000 114.000 .000
.000 .a .000 .000 .


















































































TECHCOND * PHASE *
AGE
MAJOR * AGE
TECHCOND * MAJOR *
AGE
PHASE * MAJOR * AGE




df Error df Sig.
Exact statistica. 
The statistic is an upper bound on F that yields a  lower bound on the significance level.b. 
Design: Intercept+TEC HCOND+PHASE+MAJOR+AGE+TECHCOND * PHASE+TECHCOND * MAJOR+PHASE *
MAJOR+TECHCOND * PHASE *  MAJOR+TECHCOND * AGE+PHASE * AGE+TECHCOND * PHASE * AGE+MAJOR *
AGE+TECHCOND * MA JOR * AGE+PHASE * MAJOR * AGE+TECHCOND * PHASE * MAJOR * AGE
c. 










































.995 11855.404 a 5.000 291 .000 .000
.005 11855.404 a 5.000 291 .000 .000
203.701 11855.404
a
5.000 291 .000 .000
203.701 11855.404 a 5.000 291 .000 .000
.064 .769 25.000 1475.000 .785
.937 .766 25.000 1082.519 .788
.066 .764 25.000 1447.000 .791














df Error df Sig.
Exact statistica. 
The  statistic is an upper  bound on F that yields a lower  bound on the significance level.b. 
Design: Intercept+MAJORc. 






















General Linear Model 
 
 
Tests of Between-Subjects Ef fects
.509a 5 .102 .789 .558
.445b 5 8.894E-02 1.012 .411
.429c 5 8.573E-02 .708 .618
.121d 5 2.414E-02 .252 .939
1.734e 5 .347 1.416 .218
1775.652 1 1775.652 13763.561 .000
1470.628 1 1470.628 16726.495 .000
2170.174 1 2170.174 17928.350 .000
1734.712 1 1734.712 18098.107 .000
1802.144 1 1802.144 7357.913 .000
.509 5 .102 .789 .558
.445 5 8.894E-02 1.012 .411
.429 5 8.573E-02 .708 .618
.121 5 2.414E-02 .252 .939























































of Squares df Mean Square F Sig.
R Squared  = .013 (Adjusted R Squared = -.004)a. 
R Squared = . 017 (Adjusted R Squared = .000)b. 
R Squared = .012 (Adjusted R  Squared = -.005)c. 
R Squared = . 004 (Adjusted R Squared = -.013)d. 








































.997 20250.194a 5.000 327.000 .000




309.636 20250.194a 5.000 327.000 .000
.112 1.903 20.000 1320.000 .009
.892 1.911 20.000 1085.486 .009
.118 1.914 20.000 1302.000 .009














df Error df Sig.
Exact statistica. 
The statistic is an upper bound on F that yields a  lower bound on the significance level.b. 
Design: Intercept+TEC HCONDc. 
Tests of Between-Subjects Ef fects
1.126a 4 .281 2.343 .055
.637b 4 .159 1.742 .140
.555
c
4 .139 1.188 .316
.157d 4 3.915E-02 .425 .791
3.141e 4 .785 3.394 .010
3020.113 1 3020.113 25147.417 .000
2496.569 1 2496.569 27310.096 .000
3664.627 1 3664.627 31370.415 .000
2937.302 1 2937.302 31866.423 .000
2998.389 1 2998.389 12961.106 .000
1.126 4 .281 2.343 .055
.637 4 .159 1.742 .140
.555 4 .139 1.188 .316
.157 4 3.915E-02 .425 .791























































of Squares df Mean Square F Sig.
R Squared  = .028 (Adjusted R Squared = .016)a. 
R Squared = . 021 (Adjusted R Squared = .009)b. 
R Squared = .014 (Adjusted R  Squared = .002)c. 
R Squared = . 005 (Adjusted R Squared = -.007)d. 
R Squared  = .039 (Adjusted R Squared = .028)e. 


































.997 19653.013a 5.000 331.000 .000




296.873 19653.013a 5.000 331.000 .000
.010 .689a 5.000 331.000 .632
.990 .689a 5.000 331.000 .632

















df Error df Sig.
Exact statistica. 
Design: Intercept+PHASEb. 
Tests of Between-Subjects Ef fects
2.235E-03a 1 2.235E-03 .018 .892
.177b 1 .177 1.930 .166
2.687E-05a 1 2.687E-05 .000 .988
4.169E-02c 1 4.169E-02 .456 .500
.197d 1 .197 .831 .363
2958.791 1 2958.791 24237.131 .000
2454.236 1 2454.236 26700.943 .000
3587.199 1 3587.199 30566.747 .000
2873.183 1 2873.183 31427.359 .000
2929.972 1 2929.972 12343.866 .000
2.235E-03 1 2.235E-03 .018 .892
.177 1 .177 1.930 .166
2.687E-05 1 2.687E-05 .000 .988
4.169E-02 1 4.169E-02 .456 .500























































of Squares df Mean Square F Sig.
R Squared  = .000 (Adjusted R Squared = -.003)a. 
R Squared = . 006 (Adjusted R Squared = .003)b. 
R Squared = .001 (Adjusted R  Squared = -.002)c. 
R Squared = . 002 (Adjusted R Squared = -.001)d. 


























1 .148** .038 .228** .232** .235** .343**
. .006 .487 .000 .000 .000 .000
342 342 342 342 342 340 340
.148** 1 .235** .020 .176** .088 .191**
.006 . .000 .718 .001 .104 .000
342 342 342 342 342 340 340
.038 .235** 1 .023 .194** .111* .193**
.487 .000 . .677 .000 .041 .000
342 342 342 342 342 340 340
.228** .020 .023 1 .114* .151** .151**
.000 .718 .677 . .034 .005 .005
342 342 342 342 342 340 340
.232** .176** .194** .114* 1 .182** .417**
.000 .001 .000 .034 . .001 .000
342 342 342 342 342 340 340
.235** .088 .111* .151** .182** 1 .267**
.000 .104 .041 .005 .001 . .000
340 340 340 340 340 340 340
.343** .191** .193** .151** .417** .267** 1
.000 .000 .000 .005 .000 .000 .
340 340 340 340 340 340 340
Pea rson Corre lation
Sig. (2-tailed)
N
Pea rson Corre lation
Sig. (2-tailed)
N
Pea rson Corre lation
Sig. (2-tailed)
N
Pea rson Corre lation
Sig. (2-tailed)
N
Pea rson Corre lation
Sig. (2-tailed)
N
Pea rson Corre lation
Sig. (2-tailed)
N










QC1 QC3 QC10 QC13 QC17 QC22 QC25
Correlation is significant at the 0.01 level (2-tailed).**. 
Correlation is significant at the 0.05 level (2-tailed).*. 
Correlations
1 .566 ** .416 ** .354 ** .488 ** .439 **
. .000 .000 .000 .000 .000
342 342 342 341 340 340
.566 ** 1 .584 ** .528 ** .720 ** .621 **
.000 . .000 .000 .000 .000
342 342 342 341 340 340
.416 ** .584 ** 1 .571 ** .611 ** .642 **
.000 .000 . .000 .000 .000
342 342 342 341 340 340
.354 ** .528 ** .571 ** 1 .565 ** .608 **
.000 .000 .000 . .000 .000
341 341 341 341 339 339
.488 ** .720 ** .611 ** .565 ** 1 .620 **
.000 .000 .000 .000 . .000
340 340 340 339 340 340
.439 ** .621 ** .642 ** .608 ** .620 ** 1
.000 .000 .000 .000 .000 .

























QC2 QC5 QC9 QC14 QC20 QC24
Correlation is significant at the 0.01 level (2-tailed).**. 




































1 .472 ** .396 ** .468 ** .520 ** .270 **
. .000 .000 .000 .000 .000
342 342 342 342 341 340
.472 ** 1 .283 ** .560 ** .610 ** .181 **
.000 . .000 .000 .000 .001
342 342 342 342 341 340
.396 ** .283 ** 1 .279 ** .329 ** .185 **
.000 .000 . .000 .000 .001
342 342 342 342 341 340
.468 ** .560 ** .279 ** 1 .507 ** .116 *
.000 .000 .000 . .000 .033
342 342 342 342 341 340
.520 ** .610 ** .329 ** .507 ** 1 .150 **
.000 .000 .000 .000 . .006
341 341 341 341 341 339
.270 ** .181 ** .185 ** .116 * .150 ** 1
.000 .001 .001 .033 .006 .

























QC4 QC7 QC11 QC12 QC15 QC19
Correlation is significant at the 0.01 level (2-tailed).**. 
Correlation is significant at the 0.05 level (2-tailed).*. 
Correlations
1 .219** .227** .295**
. .000 .000 .000
342 342 342 340
.219** 1 .056 .113*
.000 . .303 .037
342 342 342 340
.227** .056 1 .727**
.000 .303 . .000
342 342 342 340
.295** .113* .727** 1
.000 .037 .000 .

















QC6 QC8 QC18 QC21
Correlation is significant at the 0.01 level (2-tailed).**. 
Correlation is significant at the 0.05 level (2-tailed).*. 






































1 .641** .511** .472** -.072
. .000 .000 .000 .188
340 339 339 340 340
.641** 1 .689** .508** .055
.000 . .000 .000 .317
339 339 338 339 339
.511** .689** 1 .540** .122*
.000 .000 . .000 .025
339 338 339 339 339
.472** .508** .540** 1 .117*
.000 .000 .000 . .031
340 339 339 340 340
-.072 .055 .122* .117* 1
.188 .317 .025 .031 .





















TECH GSAT INTER COMM TIME
Correlation is significant at the 0.01 level (2-tailed).**. 











































































58.426 2816.137a 5.000 241.000 .000
58.426 2816.137a 5.000 241.000 .000
.028 1.407a 5.000 241.000 .222
.972 1.407a 5.000 241.000 .222
.029 1.407a 5.000 241.000 .222
.029 1.407a 5.000 241.000 .222
.110 1.375 20.000 976.000 .125
.894 1.370 20.000 800.256 .128
.114 1.363 20.000 958.000 .132
.054 2.644b 5.000 244.000 .024
.110 1.103 25.000 1225.000 .330
.894 1.102 25.000 896.777 .332
.115 1.099 25.000 1197.000 .335
.058 2.850b 5.000 245.000 .016
.109 1.371 20.000 976.000 .127
.893 1.382 20.000 800.256 .122
.116 1.391 20.000 958.000 .117
.082 4.002b 5.000 244.000 .002
.118 1.179 25.000 1225.000 .247
.887 1.173 25.000 896.777 .254
.122 1.165 25.000 1197.000 .261
.050 2.463b 5.000 245.000 .034
.344 .906 100.000 1225.000 .733
.699 .900 100.000 1180.388 .745
.374 .895 100.000 1197.000 .758
.122 1.489b 20.000 245.000 .085
.251 .810 80.000 1225.000 .886
.771 .810 80.000 1164.482 .885
.271 .810 80.000 1197.000 .885













































df Error df Sig.
Exact statistica. 
The statistic is an upper bound on F that yields a  lower bound on the significance level.b. 
Design: Intercept+PHASE+TECHCOND+MAJOR+PHASE * TECHCOND+PHASE * MAJOR+TECHCOND *
MAJOR+PHASE * TECHCOND * MAJOR
c. 





































Tests of  Between-Subjects Effects
18.057a 55 .328 1.190 .189
41.057b 55 .746 1.333 .074
38.471c 55 .699 1.539 .015
25.326d 55 .460 1.278 .108
12.743e 55 .232 .894 .683
1680.133 1 1680.133 6090.177 .000
1216.769 1 1216.769 2172.310 .000
1423.411 1 1423.411 3132.025 .000
2241.942 1 2241.942 6223.731 .000
1341.038 1 1341.038 5176.793 .000
.465 1 .465 1.686 .195
8.574E-02 1 8.574E-02 .153 .696
.604 1 .604 1.329 .250
5.375E-02 1 5.375E-02 .149 .700
7.295E-02 1 7.295E-02 .282 .596
2.234 4 .559 2.025 .092
4.603 4 1.151 2.054 .087
4.551 4 1.138 2.503 .043
1.193 4 .298 .828 .508
1.217 4 .304 1.174 .323
1.480 5 .296 1.073 .376
3.422 5 .684 1.222 .299
3.446 5 .689 1.517 .185
3.216 5 .643 1.786 .116
1.584 5 .317 1.223 .299
.591 4 .148 .536 .710
2.387 4 .597 1.066 .374
5.090 4 1.272 2.800 .027
3.224 4 .806 2.238 .066
.873 4 .218 .843 .499
2.078 5 .416 1.507 .188
5.094 5 1.019 1.819 .110
4.917 5 .983 2.164 .059
3.115 5 .623 1.729 .128
.610 5 .122 .471 .798
4.876 20 .244 .884 .608
7.784 20 .389 .695 .830
7.272 20 .364 .800 .713
8.425 20 .421 1.169 .282
5.152 20 .258 .994 .470
4.470 16 .279 1.013 .444
6.849 16 .428 .764 .725
5.544 16 .347 .762 .727
4.074 16 .255 .707 .786




























































































of Squares df Mean Square F Sig.
R Squared = .211 (Adjusted R Squared = .034)a. 
R Squared = . 230 (Adjusted R Squared = . 057)b. 
R Squared = .257 (Adjusted R Squared = .090)c. 
R Squared = . 223 (Adjusted R Squared = . 049)d. 
R Squared = .167 (Adjusted R Squared = -.020)e. 
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Posthoc Analyses of Significant Results  
MAJOR 

































Tests of  Between-Subjects Effects
Dependent Variable: YESGO
2.452a 5 .490 2.008 .077
63.396 1 63.396 259.685 .000












of Squares df Mean Square F Sig.
R Squared  = .032 (Adjusted R Squared = .016)a. 


































.534 .043 .450 .618
.529 .120 .294 .765
.605 .075 .456 .753
.383 .072 .241 .525
.762 .108 .550 .974

















.0042 .12721 1.000 -.3607 .3690
-.0711 .08660 .964 -.3195 .1773
.1506 .08376 .469 -.0897 .3909
-.2283 .11596 .363 -.5609 .1043
-.0478 .08660 .994 -.2962 .2006
-.0042 .12721 1.000 -.3690 .3607
-.0752 .14156 .995 -.4813 .3308
.1464 .13984 .901 -.2547 .5475
-.2325 .16120 .701 -.6949 .2299
-.0520 .14156 .999 -.4580 .3540
.0711 .08660 .964 -.1773 .3195
.0752 .14156 .995 -.3308 .4813
.2217 .10427 .277 -.0774 .5207
-.1573 .13154 .839 -.5345 .2200
.0233 .10656 1.000 -.2824 .3289
-.1506 .08376 .469 -.3909 .0897
-.1464 .13984 .901 -.5475 .2547
-.2217 .10427 .277 -.5207 .0774
-.3789* .12969 .043 -.7509 -.0069
-.1984 .10427 .402 -.4975 .1007
.2283 .11596 .363 -.1043 .5609
.2325 .16120 .701 -.2299 .6949
.1573 .13154 .839 -.2200 .5345
.3789* .12969 .043 .0069 .7509
.1805 .13154 .744 -.1968 .5578
.0478 .08660 .994 -.2006 .2962
.0520 .14156 .999 -.3540 .4580
-.0233 .10656 1.000 -.3289 .2824
.1984 .10427 .402 -.1007 .4975















































Based on observed means.
The mean difference is significant at the .05 level.*. 
























































Tests of  Between-Subjects Effects
Dependent Variable: QC2
8.884a 5 1.777 2.535 .029
2559.550 1 2559.550 3652.037 .000












of Squares df Mean Square F Sig.
R Squared  = .041 (Adjusted R Squared = .025)a. 
MAJOR
Dependent Variable: QC2
3.590 .072 3.447 3.732
3.471 .203 3.071 3.870
3.814 .128 3.563 4.065
3.298 .122 3.058 3.538
3.905 .183 3.545 4.264

















.1190 .21554 .994 -.4993 .7372
-.2244 .14673 .646 -.6453 .1965
.2917 .14192 .314 -.1154 .6988
-.3152 .19648 .596 -.8788 .2484
.1012 .14673 .983 -.3197 .5220
-.1190 .21554 .994 -.7372 .4993
-.3434 .23985 .708 -1.0313 .3446
.1727 .23694 .978 -.5069 .8523
-.4342 .27313 .606 -1.2176 .3492
-.0178 .23985 1.000 -.7057 .6702
.2244 .14673 .646 -.1965 .6453
.3434 .23985 .708 -.3446 1.0313
.5161 * .17667 .043 .0094 1.0228
-.0908 .22287 .999 -.7301 .5485
.3256 .18055 .465 -.1923 .8434
-.2917 .14192 .314 -.6988 .1154
-.1727 .23694 .978 -.8523 .5069
-.5161* .17667 .043 -1.0228 -.0094
-.6069 .21974 .067 -1.2372 .0234
-.1905 .17667 .890 -.6972 .3162
.3152 .19648 .596 -.2484 .8788
.4342 .27313 .606 -.3492 1.2176
.0908 .22287 .999 -.5485 .7301
.6069 .21974 .067 -.0234 1.2372
.4164 .22287 .424 -.2229 1.0557
-.1012 .14673 .983 -.5220 .3197
.0178 .23985 1.000 -.6702 .7057
-.3256 .18055 .465 -.8434 .1923
.1905 .17667 .890 -.3162 .6972















































Based on observed means.
The mean difference is significant at the .05 level.*. 

























































Tests of  Between-Subjects Effects
Dependent Variable: QC10
1.861a 5 .372 2.063 .070
1815.167 1 1815.167 10063.796 .000












of Squares df Mean Square F Sig.




-.0356 .10934 1.000 -.3492 .2781
.1519 .07444 .322 -.0616 .3654
.1246 .07200 .512 -.0819 .3312
-.0608 .09967 .990 -.3467 .2251
.1519 .07444 .322 -.0616 .3654
.0356 .10934 1.000 -.2781 .3492
.1874 .12167 .638 -.1616 .5364
.1602 .12020 .767 -.1846 .5050
-.0252 .13856 1.000 -.4226 .3722
.1874 .12167 .638 -.1616 .5364
-.1519 .07444 .322 -.3654 .0616
-.1874 .12167 .638 -.5364 .1616
-.0272 .08962 1.000 -.2843 .2298
-.2126 .11306 .416 -.5369 .1117
.0000 .09159 1.000 -.2627 .2627
-.1246 .07200 .512 -.3312 .0819
-.1602 .12020 .767 -.5050 .1846
.0272 .08962 1.000 -.2298 .2843
-.1854 .11147 .557 -.5052 .1343
.0272 .08962 1.000 -.2298 .2843
.0608 .09967 .990 -.2251 .3467
.0252 .13856 1.000 -.3722 .4226
.2126 .11306 .416 -.1117 .5369
.1854 .11147 .557 -.1343 .5052
.2126 .11306 .416 -.1117 .5369
-.1519 .07444 .322 -.3654 .0616
-.1874 .12167 .638 -.5364 .1616
.0000 .09159 1.000 -.2627 .2627
-.0272 .08962 1.000 -.2843 .2298















































Based on observed means.

























































Tests of  Between-Subjects Effects
Dependent Variable: QC20
9.330a 5 1.866 1.906 .093
1785.239 1 1785.239 1823.829 .000












of Squares df Mean Square F Sig.
R Squared  = .031 (Adjusted R Squared = .015)a. 







































3.226 .086 3.057 3.394
3.000 .240 2.528 3.472
2.930 .151 2.633 3.227
2.783 .146 2.496 3.070
3.190 .216 2.766 3.615

















.2256 .25483 .950 -.5054 .9565
.2953 .17356 .532 -.2025 .7932
.4430 .16923 .096 -.0425 .9284
.0351 .23232 1.000 -.6313 .7015
.3186 .17356 .444 -.1793 .8164
-.2256 .25483 .950 -.9565 .5054
.0698 .28345 1.000 -.7433 .8828
.2174 .28082 .972 -.5881 1.0229
-.1905 .32279 .992 -1.1164 .7354
.0930 .28345 .999 -.7200 .9061
-.2953 .17356 .532 -.7932 .2025
-.0698 .28345 1.000 -.8828 .7433
.1476 .20986 .981 -.4544 .7496
-.2602 .26339 .922 -1.0158 .4953
.0233 .21337 1.000 -.5888 .6353
-.4430 .16923 .096 -.9284 .0425
-.2174 .28082 .972 -1.0229 .5881
-.1476 .20986 .981 -.7496 .4544
-.4079 .26056 .622 -1.1553 .3395
-.1244 .20986 .991 -.7263 .4776
-.0351 .23232 1.000 -.7015 .6313
.1905 .32279 .992 -.7354 1.1164
.2602 .26339 .922 -.4953 1.0158
.4079 .26056 .622 -.3395 1.1553
.2835 .26339 .891 -.4720 1.0390
-.3186 .17356 .444 -.8164 .1793
-.0930 .28345 .999 -.9061 .7200
-.0233 .21337 1.000 -.6353 .5888
.1244 .20986 .991 -.4776 .7263















































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: QC23
7.267a 5 1.453 1.858 .102
1288.578 1 1288.578 1647.161 .000












of Squares df Mean Square F Sig.
R Squared  = .030 (Adjusted R Squared = .014)a. 
MAJOR
Dependent Variable: QC23
2.459 .077 2.308 2.610
2.412 .215 1.990 2.834
2.535 .135 2.269 2.800
2.783 .130 2.526 3.039
2.810 .193 2.430 3.189

















.0469 .22782 1.000 -.6066 .7004
-.0762 .15516 .996 -.5213 .3688
-.3240 .15129 .269 -.7579 .1100
-.3509 .20769 .540 -.9466 .2449
.1331 .15516 .956 -.3120 .5781
-.0469 .22782 1.000 -.7004 .6066
-.1231 .25340 .997 -.8500 .6037
-.3708 .25105 .679 -1.0910 .3493
-.3978 .28857 .740 -1.2255 .4300
.0862 .25340 .999 -.6407 .8130
.0762 .15516 .996 -.3688 .5213
.1231 .25340 .997 -.6037 .8500
-.2477 .18762 .774 -.7859 .2904
-.2746 .23547 .852 -.9501 .4008
.2093 .19075 .882 -.3379 .7565
.3240 .15129 .269 -.1100 .7579
.3708 .25105 .679 -.3493 1.0910
.2477 .18762 .774 -.2904 .7859
-.0269 .23294 1.000 -.6951 .6412
.4570 .18762 .147 -.0811 .9952
.3509 .20769 .540 -.2449 .9466
.3978 .28857 .740 -.4300 1.2255
.2746 .23547 .852 -.4008 .9501
.0269 .23294 1.000 -.6412 .6951
.4839 .23547 .314 -.1915 1.1594
-.1331 .15516 .956 -.5781 .3120
-.0862 .25340 .999 -.8130 .6407
-.2093 .19075 .882 -.7565 .3379
-.4570 .18762 .147 -.9952 .0811















































Based on observed means.
























































Tests of  Between-Subjects Effects
Dependent Variable: QC4
12.803a 5 2.561 2.258 .048
2330.023 1 2330.023 2054.625 .000












of Squares df Mean Square F Sig.
R Squared  = .033 (Adjusted R Squared = .018)a. 







































3.581 .110 3.363 3.798
3.624 .110 3.406 3.841
3.657 .127 3.407 3.908
3.659 .166 3.331 3.986
3.074 .205 2.671 3.477

















-.0430 .15617 1.000 -.4907 .4046
-.0765 .16851 .998 -.5595 .4065
-.0779 .19963 .999 -.6501 .4944
.5066 .23280 .252 -.1608 1.1739
.6640 .32665 .326 -.2724 1.6003
.0430 .15617 1.000 -.4046 .4907
-.0335 .16851 1.000 -.5165 .4495
-.0349 .19963 1.000 -.6071 .5374
.5496 .23280 .173 -.1177 1.2169
.7070 .32665 .257 -.2294 1.6433
.0765 .16851 .998 -.4065 .5595
.0335 .16851 1.000 -.4495 .5165
-.0014 .20943 1.000 -.6017 .5989
.5831 .24125 .153 -.1085 1.2746
.7405 .33272 .229 -.2133 1.6942
.0779 .19963 .999 -.4944 .6501
.0349 .19963 1.000 -.5374 .6071
.0014 .20943 1.000 -.5989 .6017
.5845 .26393 .234 -.1721 1.3410
.7419 .34952 .278 -.2600 1.7438
-.5066 .23280 .252 -1.1739 .1608
-.5496 .23280 .173 -1.2169 .1177
-.5831 .24125 .153 -1.2746 .1085
-.5845 .26393 .234 -1.3410 .1721
.1574 .36947 .998 -.9017 1.2165
-.6640 .32665 .326 -1.6003 .2724
-.7070 .32665 .257 -1.6433 .2294
-.7405 .33272 .229 -1.6942 .2133
-.7419 .34952 .278 -1.7438 .2600









































































































Tests of  Between-Subjects Effects
Dependent Variable: QC11
9.458a 5 1.892 2.553 .028
3046.457 1 3046.457 4111.282 .000












of Squares df Mean Square F Sig.
R Squared  = .037 (Adjusted R Squared = .023)a. 
AGE
Dependent Variable: QC11
3.753 .089 3.577 3.928
4.043 .089 3.867 4.219
4.029 .103 3.826 4.231
4.073 .134 3.809 4.338
3.556 .166 3.230 3.881

















-.2903 .12624 .197 -.6522 .0715
-.2759 .13621 .330 -.6663 .1146
-.3205 .16137 .353 -.7831 .1421
.1971 .18818 .901 -.3423 .7366
-.2473 .26404 .937 -1.0042 .5096
.2903 .12624 .197 -.0715 .6522
.0144 .13621 1.000 -.3760 .4049
-.0302 .16137 1.000 -.4927 .4324
.4875 .18818 .102 -.0520 1.0269
.0430 .26404 1.000 -.7139 .7999
.2759 .13621 .330 -.1146 .6663
-.0144 .13621 1.000 -.4049 .3760
-.0446 .16929 1.000 -.5299 .4407
.4730 .19501 .150 -.0860 1.0320
.0286 .26895 1.000 -.7424 .7995
.3205 .16137 .353 -.1421 .7831
.0302 .16137 1.000 -.4324 .4927
.0446 .16929 1.000 -.4407 .5299
.5176 .21335 .150 -.0940 1.1292
.0732 .28253 1.000 -.7367 .8831
-.1971 .18818 .901 -.7366 .3423
-.4875 .18818 .102 -1.0269 .0520
-.4730 .19501 .150 -1.0320 .0860
-.5176 .21335 .150 -1.1292 .0940
-.4444 .29865 .672 -1.3006 .4117
.2473 .26404 .937 -.5096 1.0042
-.0430 .26404 1.000 -.7999 .7139
-.0286 .26895 1.000 -.7995 .7424
-.0732 .28253 1.000 -.8831 .7367















































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: QC14
10.246a 5 2.049 2.623 .024
1197.201 1 1197.201 1532.311 .000












of Squares df Mean Square F Sig.
R Squared  = .038 (Adjusted R Squared = .024)a. 
AGE
Dependent Variable: QC14
2.217 .092 2.036 2.399
2.280 .092 2.099 2.460
2.343 .106 2.135 2.551
2.756 .138 2.485 3.028
2.444 .170 2.110 2.779
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-.0622 .12998 .997 -.4348 .3104
-.1255 .14019 .948 -.5273 .2764
-.5387* .16598 .016 -1.0145 -.0629
-.2271 .19347 .849 -.7816 .3275
-.4493 .27130 .562 -1.2270 .3284
.0622 .12998 .997 -.3104 .4348
-.0633 .13987 .998 -.4642 .3377
-.4765* .16570 .049 -.9515 -.0015
-.1649 .19323 .957 -.7188 .3890
-.3871 .27113 .710 -1.1643 .3901
.1255 .14019 .948 -.2764 .5273
.0633 .13987 .998 -.3377 .4642
-.4132 .17383 .167 -.9115 .0851
-.1016 .20025 .996 -.6756 .4724
-.3238 .27617 .850 -1.1155 .4679
.5387* .16598 .016 .0629 1.0145
.4765* .16570 .049 .0015 .9515
.4132 .17383 .167 -.0851 .9115
.3117 .21907 .713 -.3163 .9396
.0894 .29011 1.000 -.7422 .9211
.2271 .19347 .849 -.3275 .7816
.1649 .19323 .957 -.3890 .7188
.1016 .20025 .996 -.4724 .6756
-.3117 .21907 .713 -.9396 .3163
-.2222 .30667 .979 -1.1013 .6569
.4493 .27130 .562 -.3284 1.2270
.3871 .27113 .710 -.3901 1.1643
.3238 .27617 .850 -.4679 1.1155
-.0894 .29011 1.000 -.9211 .7422















































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: INTER
5.151a 5 1.030 2.136 .061
1881.851 1 1881.851 3901.326 .000












of Squares df Mean Square F Sig.
R Squared  = .032 (Adjusted R Squared = .017)a. 
AGE
Dependent Variable: INTER
3.134 .072 2.992 3.277
3.195 .072 3.054 3.337
3.196 .084 3.031 3.360
3.394 .108 3.181 3.608
2.852 .134 2.589 3.115




















-.0613 .10213 .991 -.3540 .2315
-.0616 .11061 .994 -.3787 .2555
-.2603 .13041 .347 -.6341 .1136
.2822 .15201 .431 -.1536 .7180
.0735 .22157 .999 -.5617 .7086
.0613 .10213 .991 -.2315 .3540
-.0003 .11035 1.000 -.3167 .3160
-.1990 .13020 .646 -.5722 .1743
.3435 .15183 .213 -.0918 .7787
.1347 .22144 .990 -.5001 .7696
.0616 .11061 .994 -.2555 .3787
.0003 .11035 1.000 -.3160 .3167
-.1987 .13695 .696 -.5913 .1939
.3438 .15766 .250 -.1082 .7958
.1350 .22548 .991 -.5113 .7814
.2603 .13041 .347 -.1136 .6341
.1990 .13020 .646 -.1743 .5722
.1987 .13695 .696 -.1939 .5913
.5425* .17213 .022 .0490 1.0359
.3337 .23583 .718 -.3424 1.0098
-.2822 .15201 .431 -.7180 .1536
-.3435 .15183 .213 -.7787 .0918
-.3438 .15766 .250 -.7958 .1082
-.5425* .17213 .022 -1.0359 -.0490
-.2088 .24843 .960 -.9209 .5034
-.0735 .22157 .999 -.7086 .5617
-.1347 .22144 .990 -.7696 .5001
-.1350 .22548 .991 -.7814 .5113
-.3337 .23583 .718 -1.0098 .3424















































Based on observed means.
The mean difference is significant at the .05 level.*. 
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TECHCOND 






















Tests of  Between-Subjects Effects
Dependent Variable: YESGO
3.868a 4 .967 4.046 .003
99.828 1 99.828 417.701 .000












of Squares df Mean Square F Sig.
R Squared  = .047 (Adjusted R Squared = .035)a. 
TECHCOND
Dependent Variable: YESGO
.500 .061 .380 .620
.750 .059 .633 .867
.544 .059 .427 .661
.438 .061 .317 .558






















-.2500* .08514 .029 -.4835 -.0165
-.0441 .08514 .986 -.2777 .1894
.0625 .08642 .951 -.1745 .2995
.0000 .08426 1.000 -.2311 .2311
.2500* .08514 .029 .0165 .4835
.2059 .08384 .104 -.0241 .4358
.3125* .08514 .003 .0790 .5460
.2500* .08295 .023 .0225 .4775
.0441 .08514 .986 -.1894 .2777
-.2059 .08384 .104 -.4358 .0241
.1066 .08514 .721 -.1269 .3402
.0441 .08295 .984 -.1834 .2716
-.0625 .08642 .951 -.2995 .1745
-.3125* .08514 .003 -.5460 -.0790
-.1066 .08514 .721 -.3402 .1269
-.0625 .08426 .947 -.2936 .1686
.0000 .08426 1.000 -.2311 .2311
-.2500* .08295 .023 -.4775 -.0225
-.0441 .08295 .984 -.2716 .1834




































Based on observed means.


























Tests of  Between-Subjects Effects
Dependent Variable: QC4
27.667a 4 6.917 6.394 .000
4224.376 1 4224.376 3905.450 .000












of Squares df Mean Square F Sig.
R Squared  = .072 (Adjusted R Squared = .061)a. 
TECHCOND
Dependent Variable: QC4
3.766 .130 3.510 4.021
3.868 .126 3.620 4.116
3.485 .126 3.237 3.733
3.031 .130 2.776 3.287
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-.1020 .18113 .980 -.5988 .3948
.2803 .18113 .532 -.2165 .7772
.7344* .18385 .001 .2301 1.2387
.1459 .17926 .926 -.3458 .6376
.1020 .18113 .980 -.3948 .5988
.3824 .17836 .204 -.1069 .8716
.8364* .18113 .000 .3396 1.3332
.2479 .17647 .625 -.2361 .7320
-.2803 .18113 .532 -.7772 .2165
-.3824 .17836 .204 -.8716 .1069
.4540 .18113 .092 -.0428 .9509
-.1344 .17647 .941 -.6185 .3496
-.7344* .18385 .001 -1.2387 -.2301
-.8364* .18113 .000 -1.3332 -.3396
-.4540 .18113 .092 -.9509 .0428
-.5885* .17926 .010 -1.0802 -.0968
-.1459 .17926 .926 -.6376 .3458
-.2479 .17647 .625 -.7320 .2361
.1344 .17647 .941 -.3496 .6185




































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: QC7
34.675a 4 8.669 8.252 .000
2420.605 1 2420.605 2304.301 .000












of Squares df Mean Square F Sig.
R Squared  = .091 (Adjusted R Squared = .080)a. 
TECHCOND
Dependent Variable: QC7
3.141 .128 2.889 3.393
2.765 .124 2.520 3.009
2.515 .124 2.270 2.759
2.172 .128 1.920 2.424
















.3759 .17850 .220 -.1137 .8655
.6259* .17850 .005 .1363 1.1155
.9688* .18118 .000 .4718 1.4657
.2815 .17666 .503 -.2031 .7660
-.3759 .17850 .220 -.8655 .1137
.2500 .17577 .614 -.2321 .7321
.5928* .17850 .009 .1032 1.0824
-.0944 .17391 .983 -.5715 .3826
-.6259* .17850 .005 -1.1155 -.1363
-.2500 .17577 .614 -.7321 .2321
.3428 .17850 .308 -.1468 .8324
-.3444 .17391 .278 -.8215 .1326
-.9688* .18118 .000 -1.4657 -.4718
-.5928* .17850 .009 -1.0824 -.1032
-.3428 .17850 .308 -.8324 .1468
-.6873* .17666 .001 -1.1718 -.2027
-.2815 .17666 .503 -.7660 .2031
.0944 .17391 .983 -.3826 .5715
.3444 .17391 .278 -.1326 .8215




































Based on observed means.
The mean difference is significant at the .05 level.*. 
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Tests of  Between-Subjects Effects
Dependent Variable: QC11
3.756a 4 .939 1.238 .294
5135.252 1 5135.252 6772.400 .000












of Squares df Mean Square F Sig.
R Squared  = .015 (Adjusted R Squared = .003)a. 
TECHCOND
Dependent Variable: QC11
3.797 .109 3.583 4.011
3.985 .106 3.778 4.193
3.897 .106 3.689 4.105
3.828 .109 3.614 4.042
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-.1884 .15165 .726 -.6044 .2276
-.1002 .15165 .965 -.5162 .3158
-.0313 .15393 1.000 -.4535 .3910
-.2876 .15009 .311 -.6993 .1241
.1884 .15165 .726 -.2276 .6044
.0882 .14934 .976 -.3214 .4979
.1572 .15165 .838 -.2588 .5731
-.0992 .14775 .962 -.5045 .3061
.1002 .15165 .965 -.3158 .5162
-.0882 .14934 .976 -.4979 .3214
.0689 .15165 .991 -.3470 .4849
-.1874 .14775 .711 -.5927 .2178
.0313 .15393 1.000 -.3910 .4535
-.1572 .15165 .838 -.5731 .2588
-.0689 .15165 .991 -.4849 .3470
-.2564 .15009 .430 -.6681 .1553
.2876 .15009 .311 -.1241 .6993
.0992 .14775 .962 -.3061 .5045
.1874 .14775 .711 -.2178 .5927
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Tests of  Between-Subjects Effects
Dependent Variable: QC12
25.415a 4 6.354 4.914 .001
1738.069 1 1738.069 1344.357 .000












of Squares df Mean Square F Sig.
R Squared  = .056 (Adjusted R Squared = .045)a. 
TECHCOND
Dependent Variable: QC12
2.500 .142 2.220 2.780
2.529 .138 2.258 2.801
2.015 .138 1.743 2.286
1.875 .142 1.595 2.155
















-.0294 .19802 1.000 -.5726 .5138
.4853 .19802 .105 -.0579 1.0285
.6250* .20100 .017 .0737 1.1763
.0211 .19599 1.000 -.5164 .5587
.0294 .19802 1.000 -.5138 .5726
.5147 .19500 .066 -.0202 1.0496
.6544* .19802 .009 .1112 1.1976
.0505 .19293 .999 -.4787 .5797
-.4853 .19802 .105 -1.0285 .0579
-.5147 .19500 .066 -1.0496 .0202
.1397 .19802 .955 -.4035 .6829
-.4642 .19293 .116 -.9934 .0650
-.6250* .20100 .017 -1.1763 -.0737
-.6544* .19802 .009 -1.1976 -.1112
-.1397 .19802 .955 -.6829 .4035
-.6039* .19599 .019 -1.1414 -.0663
-.0211 .19599 1.000 -.5587 .5164
-.0505 .19293 .999 -.5797 .4787
.4642 .19293 .116 -.0650 .9934




































Based on observed means.
The mean difference is significant at the .05 level.*. 
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Tests of  Between-Subjects Effects
Dependent Variable: QC14
20.234a 4 5.059 6.748 .000
1849.220 1 1849.220 2466.609 .000












of Squares df Mean Square F Sig.
R Squared  = .076 (Adjusted R Squared = .065)a. 
TECHCOND
Dependent Variable: QC14
2.234 .108 2.021 2.447
2.776 .106 2.568 2.984
2.368 .105 2.161 2.574
2.016 .108 1.803 2.229
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-.5417* .15134 .004 -.9569 -.1266
-.1333 .15079 .903 -.5469 .2804
.2188 .15306 .609 -.2011 .6386
-.1459 .14924 .865 -.5553 .2635
.5417* .15134 .004 .1266 .9569
.4085 .14905 .050 -.0004 .8173
.7605* .15134 .000 .3454 1.1756
.3958 .14747 .058 -.0087 .8004
.1333 .15079 .903 -.2804 .5469
-.4085 .14905 .050 -.8173 .0004
.3520 .15079 .137 -.0616 .7656
-.0126 .14692 1.000 -.4156 .3904
-.2188 .15306 .609 -.6386 .2011
-.7605* .15134 .000 -1.1756 -.3454
-.3520 .15079 .137 -.7656 .0616
-.3647 .14924 .107 -.7740 .0447
.1459 .14924 .865 -.2635 .5553
-.3958 .14747 .058 -.8004 .0087
.0126 .14692 1.000 -.3904 .4156




































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: QC15
30.987a 4 7.747 6.543 .000
2790.878 1 2790.878 2357.062 .000












of Squares df Mean Square F Sig.
R Squared  = .074 (Adjusted R Squared = .062)a. 
TECHCOND
Dependent Variable: QC15
3.125 .136 2.857 3.393
3.090 .133 2.828 3.351
2.706 .132 2.446 2.965
2.375 .136 2.107 2.643
















.0354 .19019 1.000 -.4862 .5571
.4191 .18951 .178 -.1007 .9389
.7500* .19236 .001 .2224 1.2776
-.0440 .18756 .999 -.5585 .4704
-.0354 .19019 1.000 -.5571 .4862
.3837 .18731 .245 -.1301 .8975
.7146* .19019 .002 .1929 1.2362
-.0795 .18534 .993 -.5878 .4289
-.4191 .18951 .178 -.9389 .1007
-.3837 .18731 .245 -.8975 .1301
.3309 .18951 .407 -.1889 .8507
-.4631 .18463 .091 -.9696 .0433
-.7500* .19236 .001 -1.2776 -.2224
-.7146* .19019 .002 -1.2362 -.1929
-.3309 .18951 .407 -.8507 .1889
-.7940* .18756 .000 -1.3085 -.2796
.0440 .18756 .999 -.4704 .5585
.0795 .18534 .993 -.4289 .5878
.4631 .18463 .091 -.0433 .9696




































Based on observed means.
The mean difference is significant at the .05 level.*. 
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Tests of  Between-Subjects Effects
Dependent Variable: QC24
22.295a 4 5.574 5.013 .001
2557.498 1 2557.498 2300.125 .000












of Squares df Mean Square F Sig.
R Squared  = .058 (Adjusted R Squared = .046)a. 
TECHCOND
Dependent Variable: QC24
2.714 .133 2.453 2.976
3.176 .128 2.925 3.428
2.687 .129 2.433 2.940
2.391 .132 2.131 2.650
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-.4622 .18439 .092 -.9680 .0436
.0277 .18505 1.000 -.4799 .5353
.3237 .18714 .417 -.1897 .8370
-.1871 .18251 .844 -.6877 .3135
.4622 .18439 .092 -.0436 .9680
.4899 .18151 .056 -.0080 .9878
.7858* .18364 .000 .2821 1.2896
.2751 .17892 .539 -.2157 .7658
-.0277 .18505 1.000 -.5353 .4799
-.4899 .18151 .056 -.9878 .0080
.2959 .18431 .495 -.2096 .8015
-.2148 .17960 .754 -.7075 .2778
-.3237 .18714 .417 -.8370 .1897
-.7858* .18364 .000 -1.2896 -.2821
-.2959 .18431 .495 -.8015 .2096
-.5108* .18175 .042 -1.0093 -.0122
.1871 .18251 .844 -.3135 .6877
-.2751 .17892 .539 -.7658 .2157
.2148 .17960 .754 -.2778 .7075




































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: QC25
8.465a 4 2.116 4.379 .002
3701.091 1 3701.091 7658.676 .000












of Squares df Mean Square F Sig.
R Squared  = .051 (Adjusted R Squared = .039)a. 
TECHCOND
Dependent Variable: QC25
3.238 .088 3.066 3.410
3.559 .084 3.393 3.725
3.313 .085 3.146 3.481
3.109 .087 2.938 3.280
















-.3207 .12156 .066 -.6542 .0127
-.0753 .12200 .972 -.4100 .2593
.1287 .12338 .835 -.2097 .4671
-.2267 .12032 .328 -.5567 .1033
.3207 .12156 .066 -.0127 .6542
.2454 .11966 .244 -.0828 .5736
.4494* .12107 .002 .1174 .7815
.0940 .11795 .931 -.2295 .4176
.0753 .12200 .972 -.2593 .4100
-.2454 .11966 .244 -.5736 .0828
.2041 .12151 .448 -.1292 .5373
-.1514 .11840 .705 -.4761 .1734
-.1287 .12338 .835 -.4671 .2097
-.4494* .12107 .002 -.7815 -.1174
-.2041 .12151 .448 -.5373 .1292
-.3554* .11982 .027 -.6841 -.0267
.2267 .12032 .328 -.1033 .5567
-.0940 .11795 .931 -.4176 .2295
.1514 .11840 .705 -.1734 .4761




































Based on observed means.
The mean difference is significant at the .05 level.*. 
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Tests of  Between-Subjects Effects
Dependent Variable: TECH
3.568a 4 .892 3.362 .010
3791.068 1 3791.068 14285.570 .000












of Squares df Mean Square F Sig.
R Squared  = .039 (Adjusted R Squared = .028)a. 
TECHCOND
Dependent Variable: TECH
3.274 .065 3.147 3.402
3.527 .062 3.404 3.650
3.367 .063 3.243 3.491
3.259 .064 3.132 3.386
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-.2529* .09008 .042 -.5000 -.0058
-.0924 .09041 .845 -.3403 .1556
.0154 .09143 1.000 -.2353 .2662
-.1844 .08916 .237 -.4290 .0602
.2529* .09008 .042 .0058 .5000
.1606 .08868 .369 -.0827 .4038
.2684* .08972 .025 .0223 .5145
.0686 .08741 .935 -.1712 .3083
.0924 .09041 .845 -.1556 .3403
-.1606 .08868 .369 -.4038 .0827
.1078 .09004 .753 -.1392 .3548
-.0920 .08774 .832 -.3327 .1487
-.0154 .09143 1.000 -.2662 .2353
-.2684* .08972 .025 -.5145 -.0223
-.1078 .09004 .753 -.3548 .1392
-.1998 .08879 .164 -.4434 .0437
.1844 .08916 .237 -.0602 .4290
-.0686 .08741 .935 -.3083 .1712
.0920 .08774 .832 -.1487 .3327




































Based on observed means.
The mean difference is significant at the .05 level.*. 
Descriptive Statistics
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Tests of  Between-Subjects Effects
Dependent Variable: GSAT
11.829a 4 2.957 5.309 .000
2746.072 1 2746.072 4930.242 .000












of Squares df Mean Square F Sig.
R Squared  = .061 (Adjusted R Squared = .049)a. 
TECHCOND
Dependent Variable: GSAT
2.844 .094 2.659 3.029
3.187 .091 3.007 3.366
2.846 .091 2.666 3.025
2.594 .093 2.410 2.777
















-.3427 .13097 .070 -.7019 .0166
-.0019 .13097 1.000 -.3611 .3574
.2502 .13245 .325 -.1132 .6135
-.0786 .12917 .974 -.4330 .2757
.3427 .13097 .070 -.0166 .7019
.3408 .12894 .065 -.0129 .6945
.5928* .13045 .000 .2350 .9506
.2640 .12711 .233 -.0847 .6127
.0019 .13097 1.000 -.3574 .3611
-.3408 .12894 .065 -.6945 .0129
.2520 .13045 .302 -.1058 .6098
-.0768 .12711 .974 -.4254 .2719
-.2502 .13245 .325 -.6135 .1132
-.5928* .13045 .000 -.9506 -.2350
-.2520 .13045 .302 -.6098 .1058
-.3288 .12864 .081 -.6816 .0241
.0786 .12917 .974 -.2757 .4330
-.2640 .12711 .233 -.6127 .0847
.0768 .12711 .974 -.2719 .4254




































Based on observed means.
The mean difference is significant at the .05 level.*. 
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Tests of  Between-Subjects Effects
Dependent Variable: INTER
12.029a 4 3.007 6.520 .000
3324.866 1 3324.866 7208.415 .000












of Squares df Mean Square F Sig.
R Squared  = .074 (Adjusted R Squared = .063)a. 
TECHCOND
Dependent Variable: INTER
3.315 .086 3.146 3.483
3.323 .083 3.160 3.487
3.072 .083 2.909 3.235
2.831 .085 2.664 2.998
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-.0086 .11919 1.000 -.3355 .3184
.2427 .11919 .251 -.0843 .5696
.4841* .12053 .001 .1535 .8147
.0190 .11755 1.000 -.3034 .3415
.0086 .11919 1.000 -.3184 .3355
.2512 .11734 .205 -.0706 .5731
.4927* .11871 .000 .1670 .8183
.0276 .11568 .999 -.2897 .3449
-.2427 .11919 .251 -.5696 .0843
-.2512 .11734 .205 -.5731 .0706
.2414 .11871 .252 -.0842 .5670
-.2236 .11568 .302 -.5409 .0937
-.4841* .12053 .001 -.8147 -.1535
-.4927* .11871 .000 -.8183 -.1670
-.2414 .11871 .252 -.5670 .0842
-.4650* .11706 .001 -.7862 -.1439
-.0190 .11755 1.000 -.3415 .3034
-.0276 .11568 .999 -.3449 .2897
.2236 .11568 .302 -.0937 .5409




































Based on observed means.
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Tests of  Between-Subjects Effects
Dependent Variable: COMM
2.468a 4 .617 1.624 .168
5053.295 1 5053.295 13299.934 .000












of Squares df Mean Square F Sig.
R Squared  = .019 (Adjusted R Squared = .007)a. 
TECHCOND
Dependent Variable: COMM
3.913 .078 3.760 4.065
3.893 .075 3.746 4.040
3.933 .075 3.785 4.081
3.746 .077 3.595 3.898
















.0193 .10779 1.000 -.2763 .3150
-.0201 .10817 1.000 -.3169 .2766
.1666 .10940 .548 -.1335 .4667
-.0979 .10669 .890 -.3905 .1948
-.0193 .10779 1.000 -.3150 .2763
-.0395 .10611 .996 -.3305 .2516
.1473 .10735 .646 -.1472 .4418
-.1172 .10459 .796 -.4041 .1697
.0201 .10817 1.000 -.2766 .3169
.0395 .10611 .996 -.2516 .3305
.1867 .10774 .415 -.1088 .4823
-.0777 .10499 .947 -.3657 .2103
-.1666 .10940 .548 -.4667 .1335
-.1473 .10735 .646 -.4418 .1472
-.1867 .10774 .415 -.4823 .1088
-.2645 .10625 .096 -.5559 .0270
.0979 .10669 .890 -.1948 .3905
.1172 .10459 .796 -.1697 .4041
.0777 .10499 .947 -.2103 .3657




































Based on observed means.
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PHASE 






























Tests of  Between-Subjects Effects
Dependent Variable: COMM
.293a 1 .293 .768 .381
4955.036 1 4955.036 12972.951 .000












of Squares df Mean Square F Sig.
R Squared  = .002 (Adjusted R Squared = -.001)a. 
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Appendix 
 
Medtech Project Participant Running Script 
 
Welcome to experiment number 297! 
 
Today you will watch a short video of a doctor and patient interacting. The video is just part of  
 
an interview and implies that the medical check up will come afterwards.  [INSERT  
 
TECHNOLOGY SENTENCE BELOW] 
========================= 
Condition: nothing and paper 
 
In the video the doctor might be using pen and paper to input the patient's symptoms and  
 
concerns in order to update the patient's records. 
--------------------- 
Condition: desktop computer 
 
In the video the doctor will be using a desktop computer to input the patient's symptoms and  
 




In the video the doctor will be using a handheld PDA to input the patient's symptoms and  
 
concerns in order to update the patient's records. 
------------- 
Condition: wearable computer 
 
In the video the doctor will be using a wearable computer to input the patient's symptoms and  
 
concerns in order to update the patient's records. The wearable computer consists of a visual  
 
display connected to the doctor's glasses and a handheld keyboard. 
============================= 
After watching the video you will be given some questionnaires to fill out that will evaluate your  
 
perception of the doctor-patient interaction. 
 
Are there any questions? 
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Squares df Mean Square F Sig.
PHASE = 2a. 
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Tests of  Between-Subjects Effects
Dependent Variable: YESGO
6.074a 9 .675 2.857 .003 .072
98.814 1 98.814 418.383 .000 .558
4.028 4 1.007 4.264 .002 .049
4.958E-02 1 4.958E-02 .210 .647 .001














of Squares df Mean Square F Sig.
Partial Eta
Squared
R Squared  = .072 (Adjusted R Squared = .047)a. 
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Table 3: T-tests to show individual phase by technology condition comparisons (hypotheses 2, 






.313 .578 2.286 64 .026 .2768 .12108 .03490 .51868
















95% Confidence Interval of
the Difference
t-test for Equality of Means
TECHCOND = NOTHINGa. 
Independent Samples Testa
1.869 .176 .865 66 .390 .1071 .12387 -.14016 .35445
















95% Confidence Interval of
the Difference
t-test for Equality of Means
TECHCOND = PDAa. 
Independent Samples Testa
.685 .411 -.419 66 .677 -.0451 .10763 -.25998 .16980
















95% Confidence Interval of
the Difference
t-test for Equality of Means
TECHCOND = PAPERa. 
Independent Samples Testa
6.800 .011 -1.655 65 .103 -.2045 .12353 -.45122 .04221
















95% Confidence Interval of
the Difference
t-test for Equality of Means
TECHCOND = DESKTOPa. 
Independent Samples Testa
.729 .396 -.099 70 .921 -.0119 .12035 -.25194 .22813
















95% Confidence Interval of
the Difference
t-test for Equality of Means
TECHCOND = WEARABLEa. 
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Squares df Mean Square F Sig.











Squares df Mean Square F Sig.
PHASE = 2a. 
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Squares df Mean Square F Sig.











Squares df Mean Square F Sig.
PHASE = 2a. 
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Figure Captions 
Figure 1. The 0 and 90 degree conditions for physician to patient body orientation. 
Figure 2. One clip from each of the 10 video conditions, illustrating Dr. Sanely and his medical 
office. 
Figure 3. Participant’s viewing one of the videos. 
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 0 Degree Conditions 90 Degree Conditions 
 
a. Nothing (no technology) 
 
a. Nothing (no technology) 
 
b. Paper and Pen 
 
b. Paper and Pen 
 
c. Personal Digital Assistant (PDA) 
 
c. Personal Digital Assistant (PDA) 
 
d. Desktop Computer 
 










e. Wearable Computer 
 
e. Wearable Computer 
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